The Interface between Research and
Application in the biopharmaceutical Industry.
SCHNITTSTELLE SCHINDLER provides technology
transfer and business development expertise to clients in the biopharmaceutical arena.
Improving and accelerating the transfer of innovations from basic science to the health care industry is critical in staying competitive in the biopharmaceutical landscape.
The primary goal is matching the ideal parties to achieve an optimized licensing or partnership deal in the client’s best interest.
SCHNITTSTELLE SCHINDLER consultancy founded by Dr. Ulrike Schindler, a scientist with close to 30 years of drug discovery and management experience in an international setting. Her extensive knowledge will facilitate the effective interaction between the relevant parties.
SCHNITTSTELLE SCHINDLER will catalyze this process
by working with you to create a strategy that translates your ideas into measurable results.
International Research and Management Experience.
Dr. Ulrike Schindler has almost 30 years of research and scientific leadership experience. She established and led international,
multi-disciplinary research teams across the USA, Europe and Japan. Dr. Ulrike Schindler has experience in various therapeutic areas, including small molecule drug discovery and the development of protein therapeutics. Her expertise and her significant international network are available to you.
2014 Founder of SCHNITTSTELLE SCHINDLER,
a biopharmaceutical consultancy, Germany
2011-2013 Executive Director/Head of Biologics,
Amgen Inc., USA
2007-2013 CEO, Alantos Pharmaceutical AG, Germany
2004-2011 CEO, Amgen Research GmbH, Germany
2000-2004 Managing Director, CEO, Tularik GmbH,
1993-2000 Scientist, Tularik Inc., USA
1993 Ph.D. in Biology from the University of Freiburg,
Germany, with research being conducted at the University
of Pennsylvania, PA, USA
1989-1993 Visiting Scientist at the University of
Pennsylvania, Philadelphia, PA, USA
Your Contact for Academia, Industry and Investors.
Services for Academic Institutes and Technology Transfer Offices:
Services for Start-up Biotechnology Companies:
Services for Investors and Pharmaceutical Industry:
Let SCHNITTSTELLE SCHINDLER be your partner
to find the optimized solution to your investment
opportunities and future partnerships!
Closing the Gender Gap.
Numerous studies recognized that heterogeneous teams are more innovative. Gender diversity has become a corporate performance driver!
Continuous innovation is essential for companies in the STEM (science, technology, engineering, mathematics) industry. Unfortunately, in these fields women are still underrepresented. Many young women enter STEM career paths but they are less likely to remain in these fields for many reasons.
Dr. Ulrike Schindler aims to help increase the success of young women entering the scientific field by building and fostering mentoring relationships with women in science at all career levels. She wants to reach out to women interested in a STEM career and encourage them to succeed in these fields.
VAT ID according to Sec. 27 a VAT Act:
DE 295 486 210
We accept no liability for the content of external links. The operator/user alone is responsible for the content of linked pages.
Any designs and photographs published on this site are protected by copyright and must not be used or published without written permission.